A retrospective study of the effects of small-dose aprotinin on blood loss and transfusion needs during total hip arthroplasty

European Journal of Anaesthesiology

Volumn 15, Issue 6, 1998, Pages 669-675

  Kasper, S M ^a   Elsner, F ^a   Hilgers, D ^a   Grond, S ^a   Rutt J ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Aprotinin, blood loss, surgical; Hip prosthesis; blood transfusion, autologous

Indexed keywords

APROTININ; KALLIKREIN INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ARTICLE; BLEEDING; BLOOD TRANSFUSION; BLOOD VOLUME; CONTROLLED STUDY; DOSE RESPONSE; ERYTHROCYTE; FEMALE; GENERAL ANESTHESIA; HOSPITALIZATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; RETROSPECTIVE STUDY; TOTAL HIP PROSTHESIS;

EID: 0032436736     PISSN: 02650215     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003643-199811000-00008     Document Type: Article

References (34)

1. Royston D. High dose aprotinin therapy: a review of the first five years' experience. J Cardiothorac Vasc Anesth 1992; 6: 76-100.
2. Levy JH, Pifarre R, Schaff HV, Horrow JC, Albus R, Spiess B, Rosengart TK, Murray J, Clark RE, Smith P, Nadel A, Bonney SL, Kleinfield R. A multicenter, double-blind, placebo-controlled trial of aprotinin for reducing blood loss and the requirement for donor-blood transfusion in patients undergoing repeat coronary artery bypass grafting. Circulation 1995; 92: 2236-2244.
3. Lentschener C, Benhamou D, Mercier FJ, Boyer-Neumann C, Naveau S, Smadja C, Wolf M, Franco D. Aprotinin reduces blood loss in patients undergoing elective liver resection. Anesth Analg 1997; 84: 875-881.
4. Janssens M, Joris J, David JL, Lemaire R, Lamy M. High-dose aprotinin reduces blood loss in patients undergoing total hip replacement surgery. Anesthesiology 1994; 80: 23-29.
5. Murkin JM, Shannon NA, Bourne RB, Rorabeck CH, Cruickshank M, Wyile G. Aprotinin decreases blood loss in patients undergoing revision or bilateral total hip arthroplasty. Anesth Analg 1995; 80: 343-348.
6. Wollinsky KH, Mehrkens HH, Freytag T, Geiger P, Weindler M. Does aprotinin lessen intraoperative blood loss? J Anästhesiol Intensivmed Notfallmed Schmerzther 1991; 26: 208-210.
7. D'Errico CC, Shayevitz JR, Martindale SJ, Mosca RS, Bove EL. The efficacy and cost of aprotinin in children undergoing open heart surgery. Anesth Analg 1996; 83: 1193-1199.
8. Patrassi GM, Viero M, Sartori MT, De Silvestro G, Rossaro L, Burra P, Nolli ML, Picinni P, Bassi N. Aprotinin efficacy on intraoperative bleeding and transfusion requirements in orthotopic liver transplantation. Transfusion 1994; 34: 507-511.
9. Schonberger JPAM, Everts PAM, Ercan H, Bredée JJ, Bavinck JH, Berreklouw E, Wildevuur CRM. Low-dose aprotinin in internal mammary artery bypass operation contributes to important blood saving. Ann Thorac Surg 1992; 54: 1172-1176.
10. Soilleux H, Gillon MC, Mirand A, Daibes M, Leballe F, Ecoffey C. Comparative effects of small and large aprotinin doses on bleeding during orthotopic liver transplantation. Anesth Analg 1995; 80: 349-352.
11. Haas S, Müller-Esterl W, Fritsche HM, Ascherl R, Stemberger A, Wendt P, Lechner F, Blümel G. Effect of aprotinin on the incidence of thrombosis and postoperative bleeding (abstract). Thromb Haemost 1985; 54: 99.
12. Ketterl R, Haas S, Heiss A, Fritsche HM, Lechner F, Kienzle H, Blümel G. Zur Wirkung des natürlichen Proteinaseninhibitors Aprotinin auf die Plättchenfunktion beim alloarthroplastischen Hüftgelenkersatz. Med Welt 1982; 33: 480-486.
13. Diefenbach C, Abel M, Limpers B, Lynch J, Ruskowski H, Jugert FK, Buzello W. Fatal anaphylactic shock after aprotinin reexposure in cardiac surgery. Anesth Analg 1995; 80: 830-831.
14. Thorpe CM, Murphy WG, Logan M. Use of aprotinin in knee replacement surgery. Br J Anaesth 1994; 73: 408-410.
15. The National Blood Resource Education Program Expert Panel. The use of autologous blood. JAMA 1990; 263: 414-417.
16. Nadler SB, Hidalgo JU, Bloch T. Prediction of blood volume in normal human adults. Surgery 1962; 51: 224-232.
17. Toy PTCY, Kaplan EB, McVay PA, Lee SJ, Strauss RG, Stehling LC, the Preoperative Autologous Blood Donation Study Group. Blood loss and replacement in total hip arthroplasty: a multicenter study. Transfusion 1992; 32: 63-67.
18. Goodnough LT, Johnston MFM, Toy PTCY, the Transfusion Medicine Academic Award Group. The variability of transfusion practice in coronary artery bypass surgery. JAMA 1991; 265: 86-90.
19. Chaplin Jr H, Mollison PL, Vetter H. The body/venous hematocrit ratio: its constancy over a wide hematocrit range. J Clin Invest 1953; 32: 1309-1316.
20. Goodnough LT, Bravo JR, Hsueh Y, Keating LJ, Brittenham GM. Red blood cell mass in autologous and homologous blood units: implications for risk/benefit assessment of autologous blood crossover and directed blood transfusion. Transfusion 1989; 29: 821-822.
21. Solomon MD, Rutledge ML, Kane LE, Yawn DH. Cost comparison of intraoperative autologous versus homologous transfusion. Transfusion 1988; 28: 379-382.
22. Royston D. Blood-sparing drugs: aprotinin, tranexamic acid, and epsilon-aminocaproic acid. Int Anesth Clin 1995; 33: 155-179.
23. Van Oeveren W, Harder MP, Roozendaal KJ, Eijsman L, Wildevuur CRH. Aprotinin protects platelets against the initial effect of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1990; 99: 788-798.
24. Levy JH, Bailey JM, Salmenperä M. Pharmacokinetics of aprotinin in preoperative cardiac surgical patients. Anesthesiology 1994; 80: 1013-1018.
25. Beller FK, Epstein MD, Kaller H. Distribution, half life time and placental transfer of the protease inhibitor trasylol. Thromb Diath Haemorr 1966; 16: 302-310.
26. Alvarez JM, Quiney NF, McMillan D, Joscelyne K, Connelly T, Brady P, Deal C, Wilson R. The use of ultra-low-dose aprotinin to reduce blood loss in cardiac surgery. J Cardiothorac Vasc Anesth 1995; 9: 29-33.
27. Marcel RJ, Stegall WC, Suit CT, Arnold JC, Vera RL, Ramsay MAE, O'Donnell MB, Swygert TH, Nein HAT, Whitten CW. Continuous small-dose aprotinin controls fibrinolysis during orthotopic liver transplantation. Anesth Analg 1996; 82: 1122-1125.
28. McMurray MR, Birnbaum MA, Walter NE. Intraoperative autotransfusion in primary and revision total hip arthroplasty. J Arthroplasty 1990; 5: 61-65.
29. Wuthrich B, Schmid P, Schmid ER, Tornic M, Johansson SG. IgE-mediated anaphylactic reaction to aprotinin during anaesthesia (letter). Lancet 1992; 340: 173-174.
30. Dietrich W, Späth P, Ebell A, Richter JA. Prevalence of anaphylactic reactions to aprotinin: analysis of two hundred and forty-eight reexposures to aprotinin in heart operations. J Thorac Cardiovasc Surg 1997; 113: 194-201.
31. Kasper SM, Schmidt J, Rütt J. Is aprotinin worth the risk in total hip replacement (letter)? Anesthesiology 1994; 81: 517-518.
32. Sandrelli L, Alfieri O. Need for aprotinin use notification (letter). Ann Thorac Surg 1993; 56: 1003-1004.
33. Rawle PR, Seeley HF. Assessing blood volume, blood loss, and blood replacement. Br J Hosp Med 1987; 38: 554-557.
34. Sirchia G, Giovanetti AM, McClelland DBL, Fracchia GN (eds). Safe and good use of blood in surgery (SANGUIS). Use of blood products and artificial colloids in 43 European hospitals. Luxembourg: Office for Official Publications of the European Communities, 1994.